• FirefoxInstall the new Firefox »
  •  Dow Up 0.00% Nasdaq Down 0.07%

    More On DNDN

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Dendreon Corporation (DNDN)

    -NasdaqGS
    0.13 Down 0.02(13.61%) Nov 18 - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.13
    Open:0.13
    Bid:N/A
    Ask:N/A
    1y Target Est:0.81
    Beta:2.89
    Next Earnings Date:N/A
    Day's Range:0.13 - 0.17
    52wk Range:0.11 - 3.52
    Volume:22,761,308
    Avg Vol (3m):N/A
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-1.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DNDN

    Comparison

    Symbol% ChgMkt Cap
    DNDNDown 13.61%N/A
    NWBODown 0.96%509.75M
    PGNXDown 0.53%390.68M
    SNYDown 3.06%127.50B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dendreon Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback